Get All Access for FREEMarket News & Research,
Live Transcripts & Audio,
and a whole lot more…
Medical research firm $TMO reported a decline in 4Q17 profit, owing to higher income tax provision. Earnings dropped to $528MM or $1.30 per share from $630MM or $1.59 per share in 4Q16. On an adjusted basis, earnings rose 16% to $2.79 per share. Revenues, meanwhile moved up 22% to $6.05BIl, helped by gains from acquisitions and favorable currency.
$AQUA, which provides water treatment solutions, has appointed Peter Wilver to its board of directors. Wilver, a former senior executive at $TMO, most recently served as Thermo Fisher's EVP and Chief Administrative Officer. Earlier, he held financial management roles at various industrial companies including GE, Honeywell and Grimes Aerospace.
$TMO, a leading medical technology company, has signed an agreement with life sciences firm $ILMN, under which Thermo Fisher will provide Illumina with Ion AmpliSeq technology. The tie-up will help Illumina effectively sell Ion AmpliSeq technology to researchers engaged in scientific studies on its next-generation sequencing (NGS) platforms.
Textron Aviation, a $TXT company, begun delivery to CanWest Air, a division of Nor-Alta Aviation Leasing Inc. When completed, this delivery will include nine Beechcraft King Air turboprop aircraft -- 8 King Air 250 and 1 King Air 350 aircraft -- which CanWest is buying to provide air ambulance support to Alberta Health Services in Alberta, Canada.
$TXT company Textron Aviation has obtained supplemental type certificate approval for the ‘Gogo AVANCE L5 connectivity system upgrade’ for its Cessna Citation X business jet. The system providers faster inflight connectivity speeds and enhanced network capacity. The company plans to introduce the AVANCE L5 system to more products.
$ROP's BoD declared a quarterly cash dividend of $0.4125 per share. The dividend is payable on Jan. 23, 2018 to stockholders of record as of Jan. 9, 2018. This represents an increase of 18% over the dividend paid in each quarter of 2017, or an expected $0.25 increase on an annual basis ($0.0625 on a quarterly basis).
$TXT company Textron Aviation has signed FedEx Express, a unit of $FDX, as launch customer for its new Cessna SkyCourier 408 cargo plane. FedEx, a long-time customer of Textron, will be purchasing 100 units, with an initial fleet order of 50 units and options for 50 more. The twin-engine, high-wing aircraft is expected to begin operation by 2020.
$TMO has received an unsolicited offer from TRC Capital to purchase up to one million shares of the company’s common stock for $181.75 per share in cash. According to Thermo Fisher, the offer price is about 4.43% lower than the closing price of its stock on November 17, 2017. The offer accounts for about 0.249% of the company’s outstanding shares.
Textron Aviation, a $TXT company, begun delivery to Tuareg Aviation Ltd for 10 Cessna Grand Caravan EX turboprops. The aircraft will be operated by Mack Air to provide charter, cargo and logistic services between a network of independently owned bush safari lodges in the popular Okavango Delta and Kalahari Plains regions of Botswana.
$ROP raised its FY17 guidance and now expects adjusted EPS of $9.27 to $9.33, compared to the prior guidance of $9.12 to $9.30. For 4Q17, the company expects adjusted EPS to be between $2.56 and $2.62. Adjusted EPS during 3Q17 stood at $2.36.
Diversified industrial company $ROP reported 3Q17 revenue growth of 23% to $1.16Bil, helped by growth in software and network businesses. Net income for the quarter grew to $190.3MM, or $1.84 per share, compared to $167.1MM, or $1.63 per share a year ago.
$TMO said it expects to return a total of about $240MM in capital to shareholders in fiscal 2017, entirely through dividends, with no additional share buybacks planned for the rest of the year. Thermo Fisher anticipates to generate $3.5Bil of free cash flow in 2017, which is in line with its previous estimate.
$TMO said pursuant to the acquisition of Patheon, around 9,000 employees of that company joined the Thermo Fisher team in the third quarter. Following completion, the transaction is expected to bring in total synergies of about $120MM in three years, comprising $90MM of cost synergies and $30MM of adjusted operating income benefit.
$TMO said it continues to focus on the 3-pronged growth strategy of developing high-impact innovative products, leveraging the scale in emerging markets and delivering value proposition to customers. During third quarter, the company launched two new electron microscopes for Materials Sciences and Applications and four Thermo Scientific products.